Melissa Moran, DO, explains how evolving approvals, careful off-label prescribing, and multidisciplinary collaboration can help clinicians address the high prevalence of hypoactive sexual desire disorder in peri- and postmenopausal women.
Melissa Moran, DO
Advertisement
Moran is a urology resident at Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Articles by Melissa Moran, DO
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
The ArteraAI Prostate Test: What It Is and How It Works
2
HHS requests testosterone therapy label updates, citing new safety data
3
Retrospective study suggests differences in OAB therapy persistence among older adults
4
Unmet needs and emerging solutions in MRI-guided prostate cancer care
5